瓣膜性心脏病合并心房颤动患者抗凝治疗的当前推荐：美国心脏病学会/美国心脏协会与欧洲心脏病学会/欧洲心胸外科学会指南达成一致……但并非完全同步！ - Suppr

Suppr

超能文献

Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!

作者信息

Erwin John Preston, Iung Bernard

机构信息

Department of Internal Medicine, Baylor Scott and White Central Texas, Temple, Texas, USA.

Texas A&M University College of Medicine, Temple, Texas, USA.

出版信息

Heart. 2018 Jun;104(12):968-970. doi: 10.1136/heartjnl-2017-312758. Epub 2018 Jan 11.

DOI:10.1136/heartjnl-2017-312758

PMID:29326109

Abstract

摘要

相似文献

Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!瓣膜性心脏病合并心房颤动患者抗凝治疗的当前推荐：美国心脏病学会/美国心脏协会与欧洲心脏病学会/欧洲心胸外科学会指南达成一致……但并非完全同步！

Heart. 2018 Jun;104(12):968-970. doi: 10.1136/heartjnl-2017-312758. Epub 2018 Jan 11.

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动合并心脏瓣膜病的抗栓治疗：欧洲心律协会（EHRA）和欧洲心脏病学会血栓工作组的联合共识文件，得到 ESC 心脏瓣膜病工作组、南非心脏协会（SA Heart）、心律学会（HRS）、亚太心律学会（APHRS）、南非心脏协会（SA Heart）和拉丁美洲心脏刺激和电生理学会（SOLEACE）的认可。

Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240.

Response to: 'Current recommendations for anticoagulant therapy in patients with valvular heart disease and atrial fibrillation: the ACC/AHA and ESC/EACTS Guidelines in Harmony…but not Lockstep!'.

Heart. 2018 Dec;104(24):2077. doi: 10.1136/heartjnl-2018-313851.

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.心房颤动和心脏瓣膜病患者的卒中与出血风险评分：在全国范围内队列研究中评估“心脏瓣膜病”。

Europace. 2019 Jan 1;21(1):33-40. doi: 10.1093/europace/euy151.

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.阿哌沙班与华法林在伴有心房颤动和心脏瓣膜病患者中的比较：来自心房颤动患者阿哌沙班减少卒中和其他血栓栓塞事件（ARISTOTLE）试验的结果。

Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动伴瓣膜性心脏病的抗栓治疗：欧洲心律协会（EHRA）和欧洲心脏病学会血栓工作组的联合共识文件的执行摘要，得到 ESC 瓣膜性心脏病工作组、南非心脏协会（SA Heart）、心律学会（HRS）、亚太心律学会（APHRS）、心脏心律失常学会（Cardiac Arrhythmia Society of Southern Africa，CASSA）和拉丁美洲心脏刺激和电生理学会（SOLEACE）的认可。

Thromb Haemost. 2017 Dec;117(12):2215-2236. doi: 10.1160/TH-17-10-0709. Epub 2017 Dec 6.

Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.心房颤动合并心脏瓣膜异常患者的卒中预防策略：对“瓣膜性”心房颤动的认知：欧洲心律协会调查结果

Europace. 2016 Oct;18(10):1593-1598. doi: 10.1093/europace/euw302.

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease.

Int J Cardiol. 2016 Apr 15;209:181-3. doi: 10.1016/j.ijcard.2016.02.005. Epub 2016 Feb 2.

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.心房颤动患者的管理（2006年美国心脏病学会基金会/美国心脏协会/欧洲心脏病学会及2011年美国心脏病学会基金会/美国心脏协会/心律学会推荐意见汇编）：美国心脏病学会/美国心脏协会实践指南工作组报告

Circulation. 2013 May 7;127(18):1916-26. doi: 10.1161/CIR.0b013e318290826d. Epub 2013 Apr 1.

Take-Home Messages From the Recently Updated AHA/ACC Guidelines for Atrial Fibrillation.美国心脏协会/美国心脏病学会最新房颤指南的关键信息

Am J Med. 2019 Dec;132(12):1363-1364. doi: 10.1016/j.amjmed.2019.07.021. Epub 2019 Aug 8.

引用本文的文献

Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.在英国普通实践中使用口服抗凝剂治疗老年心房颤动患者：使用临床实践研究数据库（CPRD）数据库的队列研究方案。

BMJ Open. 2019 Dec 15;9(12):e032646. doi: 10.1136/bmjopen-2019-032646.

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study.2型心脏瓣膜病影响心房颤动患者抗凝治疗的决策：UMBRIA-心房颤动前瞻性研究

TH Open. 2019 Jun 5;3(2):e157-e164. doi: 10.1055/s-0039-1692202. eCollection 2019 Apr.

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis.新型口服抗凝剂与华法林在伴有心房颤动和心脏瓣膜病患者中的比较：系统评价和荟萃分析。

Drugs R D. 2019 Jun;19(2):117-126. doi: 10.1007/s40268-019-0274-z.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验